These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 18808168

  • 21. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog.
    Dijkgraaf I, Franssen GM, McBride WJ, D'Souza CA, Laverman P, Smith CJ, Goldenberg DM, Oyen WJ, Boerman OC.
    J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H, Desai P, Koike Y, Houghton J, Carlin S, Tandon N, Touijer K, Weber WA.
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
    Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR.
    J Nucl Med; 2011 Dec; 52(12):1970-8. PubMed ID: 22080443
    [Abstract] [Full Text] [Related]

  • 26. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.
    Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ.
    Bioconjug Chem; 2003 Dec; 14(4):756-63. PubMed ID: 12862428
    [Abstract] [Full Text] [Related]

  • 27. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
    La Bella R, Garcia-Garayoa E, Bahler M, Bläuenstein P, Schibli R, Conrath P, Tourwé D, Schubiger PA.
    Bioconjug Chem; 2002 Dec; 13(3):599-604. PubMed ID: 12009951
    [Abstract] [Full Text] [Related]

  • 28. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors.
    Maina T, Kaloudi A, Valverde IE, Mindt TL, Nock BA.
    Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR.
    Clin Cancer Res; 2009 Aug 15; 15(16):5240-9. PubMed ID: 19671861
    [Abstract] [Full Text] [Related]

  • 31. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z, Mitran B, Rosenström U, Velikyan I, Rosestedt M, Lindeberg G, Sörensen J, Larhed M, Tolmachev V, Orlova A.
    Nucl Med Biol; 2015 May 15; 42(5):446-454. PubMed ID: 25684649
    [Abstract] [Full Text] [Related]

  • 32. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH, Dayananda K, Chen CY, Liu GC, Luo TY, Hsu HS, Wang YM.
    Bioorg Med Chem; 2011 Feb 01; 19(3):1085-96. PubMed ID: 20493715
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L, Yu P, Veerendra B, Rold TL, Retzloff L, Prasanphanich A, Sieckman G, Hoffman TJ, Volkert WA, Smith CJ.
    Mol Imaging; 2007 Feb 01; 6(3):171-80. PubMed ID: 17532883
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors.
    Zhang H, Chen J, Waldherr C, Hinni K, Waser B, Reubi JC, Maecke HR.
    Cancer Res; 2004 Sep 15; 64(18):6707-15. PubMed ID: 15374988
    [Abstract] [Full Text] [Related]

  • 35. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU, Martens JW, Sieuwerts AM, van Deurzen CH, Koelewijn SJ, de Blois E, Maina T, Nock BA, Brunel L, Fehrentz JA, Martinez J, de Jong M, Melis M.
    J Nucl Med; 2015 May 15; 56(5):752-7. PubMed ID: 25791989
    [Abstract] [Full Text] [Related]

  • 36. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU, Veerendra B, Figueroa SD, Sieckman GL, Rold TL, Hoffman TJ, Smith CJ, Pietzsch HJ.
    Bioconjug Chem; 2007 May 15; 18(5):1651-61. PubMed ID: 17663527
    [Abstract] [Full Text] [Related]

  • 37. A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.
    Schroeder RP, Müller C, Reneman S, Melis ML, Breeman WA, de Blois E, Bangma CH, Krenning EP, van Weerden WM, de Jong M.
    Eur J Nucl Med Mol Imaging; 2010 Jul 15; 37(7):1386-96. PubMed ID: 20182713
    [Abstract] [Full Text] [Related]

  • 38. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, Volkert WA, Hoffman TJ.
    Cancer Res; 2003 Jul 15; 63(14):4082-8. PubMed ID: 12874010
    [Abstract] [Full Text] [Related]

  • 39. Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models.
    Pujatti PB, Foster JM, Finucane C, Hudson CD, Burnet JC, Pasqualoto KFM, Mengatti J, Mather SJ, de Araújo EB, Sosabowski JK.
    Appl Radiat Isot; 2015 Feb 15; 96():91-101. PubMed ID: 25479439
    [Abstract] [Full Text] [Related]

  • 40. Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.
    Yang YS, Zhang X, Xiong Z, Chen X.
    Nucl Med Biol; 2006 Apr 15; 33(3):371-80. PubMed ID: 16631086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.